{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-038547","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.773247+00:00","generated_at":"2026-05-31T01:05:46.452531+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Palisade Bio revises CEO/CFO J.D. Finley's employment agreement; salary unchanged","bullets":["Base salary stays at $542,000 per year; target bonus remains up to 50% of base.","Non-CIC severance: 12 months base salary continuation plus COBRA premiums.","CIC severance: lump sum of 18 months base plus 100% target bonus, 18 months COBRA, full acceleration of time-based equity.","Agreement is at-will; executive must sign release for severance benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-038547","json":"https://secwatch.observer/filing/0001493152-24-038547.json","markdown":"https://secwatch.observer/filing/0001493152-24-038547.md","text":"https://secwatch.observer/filing/0001493152-24-038547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/0001493152-24-038547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:05:46.452531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}